Back to home

disclosure · FTC

The Mental Health Creator Disclosure Checklist for 2026

Therapy, meditation, and nootropic brands all run under FTC endorsement rules. The Cerebral $7M order shows what goes wrong at scale. Here is the 8-point pre-publish check.

By Dennis Ksendzov, Founder, Influencer Advisory6 min read
On this page

The proposed FTC order in April 2024 required Cerebral to pay $7 million for using and disclosing sensitive patient data for advertising.

A founder asked us last week if her therapy brand could still hire creators who had posted about Cerebral in the past.

The honest answer was yes, with three changes to the brief.

That one-minute review is the work most mental-health brands skip.

Disclosure rules bind every mental-health creator. The same rule, FTC 16 CFR Part 255, covers therapy brands, meditation apps, and nootropic supplements. The brief changes by product. The rule does not.

A brand that runs creators without an 8-point check ships disclosure failures the FTC will see.

The rule that binds every mental-health creator

The rule is short.

16 CFR Part 255 requires anyone endorsing a product for compensation to disclose the material connection clearly and conspicuously.

That covers all three mental-health categories.

A BetterHelp creator running a paid therapy promotion. A Headspace creator running a paid meditation integration. A Magic Mind creator running a paid supplement shot.

The disclosure must appear at the start of the integration.

The wording must be plain. "Paid partnership," "sponsored," "ad." Not "thanks for supporting." Not "in collaboration with."

The format must match the medium. A YouTube video needs verbal and on-screen disclosure. An Instagram Reel needs caption and overlay disclosure. A TikTok needs the same.

The FTC influencer hub lays out the consumer-facing version of the rule.

The 2023 update tightened the "clear and conspicuous" standard. Font size matched to surrounding content. Audio volume matched. Position at the start, not the end.

A creator who learned the rule before 2023 may still be running an old script. The brand has to update the brief.

What the Cerebral and BetterHelp cases changed

Two FTC cases reset the mental-health disclosure bar.

The BetterHelp 2023 settlement was about data sharing, not creator disclosure directly. But it raised the brand-safety bar across the category. Legal teams now ask for explicit creator scripts before signing any therapy deal.

The Cerebral 2024 case extended the data-and-advertising rule.

The proposed FTC order will prohibit Cerebral from using or disclosing sensitive consumer data for most advertising purposes, and will require the company to pay $7 million.

That is from the FTC press release in April 2024. The text is verifiable at the FTC source.

The order does not directly bind creators. It binds the brand. But brand legal teams now require creators to use only the data and language the brand pre-clears.

That means three changes to the brief in 2026.

Creators get a legal-cleared script. The script lists the exact claim language allowed.

Creators run disclosure at the start, not the end.

Creators cannot link to disease-specific landing pages without brand approval.

The BetterHelp creator pool reflects the change. The top 50 BetterHelp creators we track disclose at 78% of posts. The wider pool of 1,598 BetterHelp creators discloses at 13.6%. The gap is the difference between vetted and unvetted.

The vetted side is the only side that survives the next FTC sweep.

The eight-point pre-publish check

Before a creator publishes a mental-health integration, run the check.

One. Disclosure at the start. Verbal in the first 30 seconds, on-screen overlay in the same window.

Two. Plain-word disclosure. "Paid partnership with X," "sponsored by X," "ad for X." Not "thanks to X."

Three. Disclosure format matched to medium. YouTube needs verbal and overlay. Instagram needs caption and overlay. TikTok needs caption and overlay.

Four. Claim language scoped. Therapy brands cannot promise cure or specific clinical outcome. Meditation apps cannot promise sleep result. Nootropic supplements cannot treat, cure, or prevent any condition.

Five. No off-brand link. The link in the description points to the creator's referral URL, not a third-party landing page. The brand pre-cleared the URL.

Six. Brand-safety review of the surrounding video. The integration should not sit inside content that includes substance use, self-harm references, or unverified medical advice.

Seven. Editorial separation. The creator's personal opinion is labeled as opinion, not clinical guidance.

Eight. Closing language audit. The last 15 seconds of the integration repeats the disclosure or routes the viewer to a disclosure-clean call to action.

Eight points, fifteen minutes per video, every video.

The 50-creator BetterHelp top tier passes this check at 78%. The bottom 1,500 pass at under 5%.

The gap is the disclosure-failure risk a brand takes on when it pitches without the check.

Why controversy brands need extra care

Some mental-health brands carry an active controversy flag.

Cerebral after the DEA investigation and FTC $7M order.

Done after the prescribing-practice investigation.

These brands still pay for creators. The deals still close. But the disclosure brief is stricter.

Three rules we apply to controversy-brand pitches.

The creator must be informed of the controversy in writing before signing. Not in the brief, in a separate notice.

The disclosure script must include an extra line. "I am paid to share my experience and your results may vary."

The creator must avoid clinical claims entirely. No "this worked for me" framed as a recommendation. Only personal experience, opinion-labeled.

Brands that skip these steps run into two failure modes. The creator publishes a clinical claim and the FTC flags the post. Or the creator publishes a generic claim and the audience flags the brand for hiding the controversy.

A brand that wants to scale a controversy creator without the extra brief is buying the next FTC headline.

How to write a disclosure line that passes

The line is short.

"This video is sponsored by [BRAND]."

That sentence at second 0 passes.

For audio-only, the same sentence at second 0 passes.

For Instagram caption, "Paid partnership with [BRAND]" at the start of the caption passes. Buried in the caption does not.

For TikTok, the on-screen caption "ad" or "sponsored" in the first frame passes. Below the fold does not.

Three patterns that fail.

"Thanks to [BRAND] for supporting this channel." Not plain enough. Not at start.

"In partnership with [BRAND]." Plain enough, but only if at the start.

"#ad" without a verbal disclosure on a YouTube video. The text-only disclosure fails on a video medium.

The patterns that pass are dull. That is the point. Dull disclosure beats clever marketing every time.

Where we come in. We run the 8-point check on every mental-health integration before it ships. The creators in our database who pass the check are the ones we shortlist for therapy, meditation, and nootropic pitches.

The data behind the check is real. 3,617 BetterHelp deals across 1,598 creators, 308 Magic Mind deals across 131 creators, and the disclosure rate on every post.

We tell you the names that pass and the names that fail.

Speak with us when you want the disclosure brief built into the pitch.

Disclosure first.


Further reading from our database:

External references:

Frequently Asked Questions

Is the BetterHelp 2023 FTC settlement still relevant in 2026?

Yes.

The settlement set the bar for what counts as a data and disclosure failure in mental health.

The Cerebral $7M order in 2024 followed the same pattern.

Both cases are why brand legal teams now require explicit creator disclosure language for therapy and psychiatry deals.

The pattern keeps going.

Do meditation apps need the same disclosure as therapy brands?

Same FTC rule, different brief.

Calm and Headspace both require '#ad' or 'sponsored' on the post and a verbal disclosure inside the integration.

The difference is the claim language.

A meditation app cannot promise the user will sleep better, only that the app offers sessions designed for sleep.

Therapy brands have stricter clinical-claim limits.

What does 'clear and conspicuous' actually mean in 2026?

Three things.

The disclosure appears at the start of the integration, not buried at the end.

The font or audio is the same size and volume as the surrounding content.

The wording is plain (paid partnership, sponsored, ad). 'Thanks to X for supporting' alone does not pass.

The 2023 update to 16 CFR Part 255 tightened all three.

Why are Cerebral and Done called controversy brands?

Cerebral was investigated by the DEA over controlled-substance prescribing practices and paid the FTC $7M in 2024 over privacy violations.

Done was investigated over similar prescribing practices.

Both brands still pay for influencer deals, but most agencies require extra creator-disclosure language and brand-safety review before signing.

Can a nootropic creator say a product treats anxiety?

No.

Nootropics are sold as dietary supplements under FDA rules.

The creator cannot say the product treats, cures, or prevents any condition.

The creator can describe a personal routine and a felt outcome, but not a clinical result.

This is the fastest disqualifier in our nootropic vetting pass.

Frequently asked

  • Is the BetterHelp 2023 FTC settlement still relevant in 2026?

    Yes. The settlement set the bar for what counts as a data and disclosure failure in mental health. The Cerebral $7M order in 2024 followed the same pattern. Both cases are why brand legal teams now require explicit creator disclosure language for therapy and psychiatry deals. The pattern keeps going.

  • Do meditation apps need the same disclosure as therapy brands?

    Same FTC rule, different brief. Calm and Headspace both require '#ad' or 'sponsored' on the post and a verbal disclosure inside the integration. The difference is the claim language. A meditation app cannot promise the user will sleep better, only that the app offers sessions designed for sleep. Therapy brands have stricter clinical-claim limits.

  • What does 'clear and conspicuous' actually mean in 2026?

    Three things. The disclosure appears at the start of the integration, not buried at the end. The font or audio is the same size and volume as the surrounding content. The wording is plain (paid partnership, sponsored, ad). 'Thanks to X for supporting' alone does not pass. The 2023 update to 16 CFR Part 255 tightened all three.

  • Why are Cerebral and Done called controversy brands?

    Cerebral was investigated by the DEA over controlled-substance prescribing practices and paid the FTC $7M in 2024 over privacy violations. Done was investigated over similar prescribing practices. Both brands still pay for influencer deals, but most agencies require extra creator-disclosure language and brand-safety review before signing.

  • Can a nootropic creator say a product treats anxiety?

    No. Nootropics are sold as dietary supplements under FDA rules. The creator cannot say the product treats, cures, or prevents any condition. The creator can describe a personal routine and a felt outcome, but not a clinical result. This is the fastest disqualifier in our nootropic vetting pass.